Evren Technologies uses the latest research and development to create an effective new treatment for PTSD. Using groundbreaking vagus nerve stimulation therapy, the Phoenix earbud will help people easily manage their symptoms and improve recovery outcomes.
100% of participants wanted to keep using the Phoenix after our pilot trial ended!
We have been recognized for our work by:
FDA Breakthrough Device Designation
MedTech Innovator Accelerator
2021 Rosenman Innovator
GuideWell Scale Up Accelerator
Life Science Health Innovation Hub
Perks of Investing
You can help millions of people suffering from debilitating symptoms of PTSD. Even with current therapies and medications, 66% of patients are still seeking new solutions to alleviate their symptoms. The Phoenix reduces symptom severity and improves quality of life with no side effects.
You can start investing in Evren Technologies for as little as $399!
Benefits of early investing include:
$1,000+ Investment - 50% off device
$5,000+ Investment - 5% Bonus Shares + 50% off device
$10,000+ Investment - 10% Bonus Shares + 50% off 2 devices
$25,000+ Investment - 20% Bonus Shares + 50% off 3 devices
$50,000+ Investment - 25% Bonus Shares + 50% off 4 devices
The PTSD treatment market is $22.5B in the U.S. alone, with approximately 15M people suffering symptoms every year. Our device leverages improvements on existing technologies, allowing for easier use and better results.
Evren Technologies is dedicated to improving the lives of soldiers afflicted with Acute Stress Reactions. In April of 2022, Evren Technologies was awarded a $172K contract from the military in order to support soldier safety and performance.
How to Invest
We envision a better future for people suffering from PTSD and with help from investors like you, we can make this dream a reality.
Read more about investment opportunities by visiting our raise page. Please help spread the word by sharing with your network!